6 results
10-K
2021 FY
VERV
Verve Therapeutics Inc
14 Mar 22
Annual report
7:04am
for the disease, known as HoFH. HoFH is typically more severe than HeFH.
Men and women with untreated HeFH typically have LDL-C levels ranging from … to about 1.3 million patients in the United States. Men and women with HoFH have LDL-C levels above 500 mg/dL and typically develop ASCVD before
424B4
VERV
Verve Therapeutics Inc
17 Jun 21
Prospectus supplement with pricing info
4:50pm
homozygous for the disease, known as HoFH. HoFH is typically more severe than HeFH.
Men and women with untreated HeFH typically have LDL-C levels ranging … translates to about 1.3 million patients in the United States. Men and women with HoFH have LDL-C levels above 500 mg/dL and typically develop ASCVD
S-1/A
VERV
Verve Therapeutics Inc
14 Jun 21
IPO registration (amended)
6:15am
is typically more severe than HeFH.
Men and women with untreated HeFH typically have LDL-C levels ranging from approximately 200 to 400 mg/dL … in the United States. Men and women with HoFH have LDL-C levels above 500 mg/dL and typically develop ASCVD before the age of 20 and, without
S-1
VERV
Verve Therapeutics Inc
28 May 21
IPO registration
4:04pm
homozygous for the disease, known as HoFH. HoFH is typically more severe than HeFH.
Men and women with untreated HeFH typically have LDL-C levels ranging … translates to about 1.3 million patients in the United States. Men and women with HoFH have LDL-C levels above 500 mg/dL and typically develop ASCVD
DRS
3snm2gii4 paw0p
16 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next